CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-27 | ORBIMED ADVISORS LLC Director | Sale | −1,176,332 | $4.16 | $4.9M | 7,165,006 |
| 2025-06-27 | Thompson Peter A. Director | Sale | −1,176,332 | $4.16 | $4.9M | 7,165,006 |
| 2021-10-01 | EcoR1 Capital, LLC 10% owner | Sale | −2,000,000 | $4.96 | $9.9M | 81,077 |
| 2021-09-30 | EcoR1 Capital, LLC 10% owner | Sale | −3,000,000 | $5.04 | $15.1M | 2,081,077 |
| 2021-09-20 | ORBIMED ADVISORS LLC Director | Sale | −1,109,644 | $6.09 | $6.8M | 6,943,654 |
| 2021-09-20 | Thompson Peter A. Director | Sale | −1,109,644 | $6.09 | $6.8M | 6,943,654 |
| 2020-07-08 | Novo Holdings A/S 10% owner | Sale | −741,440 | $5.37 | $4.0M | 1,389,498 |
| 2020-07-07 | Novo Holdings A/S 10% owner | Sale | −796,622 | $5.25 | $4.2M | 2,130,938 |
| 2019-07-25 | Novo Holdings A/S 10% owner | Sale | −1,400,000 | $4.00 | $5.6M | 2,927,560 |
| 2019-07-24 | Novo Holdings A/S 10% owner | Sale | −53,240 | $5.01 | $267K | 4,327,560 |
| 2019-07-23 | Novo Holdings A/S 10% owner | Sale | −39,716 | $5.32 | $211K | 4,380,800 |
Page 1 of 1 · 11 trades